A Study of Pregnancy Outcomes in Congenital Heart Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The purpose of this study is to determine if a biomarker assay obtained peripartum (1st-3rd trimester and post-partum) in patients with adult congenital heart disease can predict future risk of cardiovascular adverse events and determine if temporal changes in biomarkers levels throughout the peripartum period can provide a better risk prediction compared to samples taken at a single time-point.
Epistemonikos ID: 802eee31809756bc6e12264725786799e5be4538
First added on: Dec 01, 2024